Global Mastitis Market - Industry Trends and Forecast to 2028

Market Analysis and Insights: Global Mastitis Market

Global mastitis market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR 6.90% in the above-mentioned research forecast period. Emerging markets and huge investments in research and development are the factors responsible for the growth of this market.

However, technological advancement in the treatment and diagnosis of breast infection also boost up the market growth. Moreover, rising cases of breast cancer and increasing rate of pregnancy also boost up the market growth. But, an adverse effect related to the treatment, lack of awareness in developing countries, and complications in diagnosis due to similar symptoms of breast cancer may hamper the global Mastitis market.

Mastitis is the condition in which inflammation occurs in breast tissue that sometimes involves an infection. Mastitis majorly affects breast-feeding women; however, mastitis can occur in women who aren't breast-feeding and in men. The inflammation may result in breast pain, swelling, warmth and redness or the patient may feel fever and chills. It is most commonly occurs after one to three of delivery and it can also occur in women who have not recently delivered and in women after menopause. The main causes of mastitis are blocked in the milk duct, a bacterial infection in the breast and others. 

According to Nestle Nutrition Institution, Lactation Mastitis affects approximately 2–10% of all breastfeeding women and incidence may vary from one population to another, with some studies quoting rates as high as 30%. The incidence of pus Mastitis was found to be approximately 0.1–3%.

This mastitis market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Mastitis Market Scope and Market Size

The mastitis market is segmented on the basis of type, diagnosis, treatment, medication, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• On the basis of type, the mastitis market is segmented into infectious mastitis, non-infectious mastitis and others.
• On the basis of diagnosis, the mastitis market is segmented into physical examination, milk sample examination and others.
• On the basis of treatment, the mastitis market is segmented into medication, physical therapy and others.
• On the basis of medication, the mastitis market is segmented into antibiotics, NSAIDs and others.
• On the basis of end-users, the mastitis market is segmented into hospitals, specialty clinics, home healthcare and others.
• On the basis of distribution channel, the mastitis market has been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.

Mastitis Market Country Level Analysis

Mastitis market is analysed and market size information is provided by country type, diagnosis, treatment, medication, end-users and distribution channel as referenced above.

The countries covered in the mastitis market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.

On geographical estimation, North America accounts the largest market share due to the presence of high healthcare expenditure and research and development. Europe accounts the second largest market share due to increased lactating mother population and presence of refined medical facilities. Asia-Pacific is expected to account for the largest market share over coming years for the mastitis market due to increased advancement in the technology as well as growing healthcare expenditure and rising awareness program.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Mastitis market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Mastitis Market Share Analysis

Mastitis market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to mastitis market.

The major players covered in the mastitis market are Teva Pharmaceutical Industries Ltd., LUPIN, Hikma Pharmaceuticals PLC, Alkem Labs Ltd., PRAGMA therapeutics, Sandoz AG, GlaxoSmithKline Plc., Par Pharmaceutical Ltd., Amneal Pharmaceutical Inc., Mylan N.V., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories, Aurobindo Pharma Limited, Perrigo Company plc., Akron Inc., and Cosette Pharmaceuticals. among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-58932